Tocotrienols for Obesity of Postmenopausal Women

Running, not enrolling · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Obesity, Postmenopausal Women

In brief

Postmenopausal women are at a risk of excessive weight gain, bone loss, hypertension, and metabolic syndrome. Obesity-induced chronic low-grade inflammation is initiated by excess nutrients in metabolic cells. Recent studies have indicated tocotrienols (one kind of vitamin E, a potent antioxidant) supplement may be good for mitigating negative impacts of obesity in postmenopausal women. The purpose of the study is to examine the effect of 24-week tocotrienols on obesity-associated outcome measurements in postmenopausal women. The investigators will enroll 60 qualified women at the start of the study and randomly assigned to no tocotrienols (placebo) or tocotrienols group for 24 weeks. Obesity-associated measurements will be recorded using blood, urine, adipose tissue, and fecal samples. All data will be analyzed statistically.

Key facts

Study ID

NCT03705845

Run by

Texas Tech University Health Sciences Center

People needed

60

Starts

2019-03-15

Expected to finish

2025-12-30

Last updated by the study team

2025-03-28

Who can join

Age: any. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• PMW with BMI ≥30 kg/m2.
• Normal liver, kidney, and thyroid function (TSH)-sent to Quest Diagnostic Laboratory.
• Sedentary using International Physical Activity Questionnaire (IPAQ-short form).

You may not qualify if…

• Unstable body weight (more than 5% change in body weight) within 3 months before intervention begins.
• Changes to medications or supplements (i.e., steroids, statins) within 3 months of the baseline study visit that could affect lipid metabolism. • If they change any medications/supplements after the baseline visit that will affect lipid metabolism, their study participation will end.
• Taking anticoagulants that may interact with TT.
• Serious chronic disease (e.g., unstable cardiovascular disease, uncontrolled diabetes and hypertension, and active cancer).

Where it is running

• Texas Tech University Health Sciences Center — Lubbock, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.